Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.03 from other evidence | 0.00 |
| cell type Human Protein Atlas | not detected in single-cell data | 0.00 |
| chemistry Open Targets | reachable by antibody | 0.45 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 4 Parkinson's papers of 1,963 | 0.79 |
| pathways Reactome | 6 pathways; mostly immune signalling | 0.90 |
No case: the score is under the bar. Receipt 6399
Sealed predictions
- C4A in dopamine neurons, braak-0.84 (p 0.004) → -0.22 (p 0.570)receipt 6406
Swarm cases
receipt 6406: C4A in dopamine neurons, braak
- power
- full sample -0.57 (p 0.013, n 18), 95% CI -0.82 to -0.14. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: -0.59 (p 0.011, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.72 (p 7.0e-4, n 18). not the mix.
- skeptic
- leave-one-out range -0.67 to -0.51, sign flips 0; without severely affected donors -0.57 (p 0.013, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for C4A in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts